Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 116.2M | 99.8M | 98.2M | 91.4M |
Selling general and admin | 29.4M | 30.1M | 24.9M | 25.2M |
Other operating expenses | — | — | — | — |
Operating income | -145.6M | -129.8M | -123.2M | -116.6M |
Non operating interest income | ||||
Income | 12.6M | 15.2M | 16.0M | 17.6M |
Expense | — | — | — | — |
Other income expense | — | 0 | — | — |
Pretax income | -133.0M | -114.7M | -107.2M | -99.0M |
Tax provision | — | — | — | — |
Net income | -133.0M | -114.8M | -107.2M | -99.0M |
Basic EPS | -0.8 | -0.7 | -0.6 | -0.6 |
Diluted EPS | -0.8 | -0.7 | -0.6 | -0.6 |
Basic average shares | 171.2M | 170.1M | 169.5M | 168.8M |
Diluted average shares | 171.2M | 170.1M | 169.5M | 168.8M |
EBITDA | -142.4M | -127.2M | -120.9M | -114.7M |
Net income from continuing op. | -133.0M | -114.8M | -107.2M | -99.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |